Truist Financial
AVNS

Truist Financial’s Avanos Medical AVNS Stock Holding History

Truist Financial’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,216
Closed -$466K – 2586
2023
Q2 		$466K Sell
18,216
-4,913
-21% -$129K ﹤0.01% 1997
2023
Q1 		$688K Buy
23,129
+5
+0% +$145 ﹤0.01% 1772
2022
Q4 		$626K Buy
+23,124
New +$565K ﹤0.01% 1803
2022
Q3 		– Sell
-16,640
Closed -$455K – 2523
2022
Q2 		$455K Buy
+16,640
New +$478K ﹤0.01% 1962
2021
Q1 		– Sell
-2,831
Closed -$130K – 2629
2020
Q4 		$130K Buy
+2,831
New +$118K ﹤0.01% 2443
2015
Q3 		– Sell
-5,011
Closed -$203K – 824
2015
Q2 		$203K Sell
5,011
-1,612
-24% -$72.4K 0.01% 755
2015
Q1 		$326K Sell
6,623
-145
-2% -$6.72K 0.01% 637
2014
Q4 		$307K Buy
+6,768
New +$266K 0.01% 626

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Truist Financial's AVNS Position: Q3 2023 in Review

Truist Financial sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 18,216 shares — an estimated $466K sold.

Truist Financial first reported a position in AVNS in Q4 2014 and held it in 8 quarters. The position peaked at $688K in Q1 2023. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • Truist Financial reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • Truist Financial sold 18,216 Avanos Medical shares in Q3 2023, an estimated $466K.
  • Truist Financial first reported a position in Avanos Medical in Q4 2014 and held it in 8 quarters.
  • Truist Financial's Avanos Medical position peaked at $688K in Q1 2023.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Truist Financial's 13F filing for Q3 2023, filed 14 Nov 2023.